Skip to content

Clinical trials

Phase 3 Retinal Degeneration trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Retinal Degeneration Phase: Phase 3 Country / region: France Clear all

6 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20131
20191
20202
20211
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed3
Terminated2
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Kodiak Sciences Inc2
AbbVie1
Centre Hospitalier Intercommunal Creteil1
Novartis Pharmaceuticals1
Opthea Limited1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Eye Diseases6
Retinal Degeneration6
Retinal Diseases6
Macular Degeneration4
Vision Disorders4
Wet Macular Degeneration4
Choroidal Neovascularization2
Macular Edema2
Vision, Low2
Blindness1

Trials

Showing 1 to 6 of 6. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.